Research Article| Volume 19, ISSUE 2, P259-272, March 1997

Ketorolac, prednisolone, and dexamethasone for postoperative inflammation

      This paper is only available as a PDF. To read, Please Download here.


      This 6-week, partially masked, three-arm, multicenter study was conducted to evaluate the postoperative anti-inflammatory efficacy of ketorolac, a cyclooxygenase inhibitor. The study setting was the clinical practice of six ophthalmic surgeons. The study enrolled 157 candidates for routine extracapsular cataract extraction or phacoemulsification and posterior-chamber intraocular lens implantation. Patients who received any glucocorticoid or cyclooxygenase inhibitor within 1 week of surgery were excluded. All patients were treated with solutions of 0.5% ketorolac, 1% prednisolone acetate, or 0.1% dexamethasone instilled into the operative eye three times daily from 1 day before surgery to 4 weeks after surgery. Efficacy variables included the signs of anterior-segment inflammation, primarily cells and flare in the anterior chamber, as observed by slit-lamp biomicroscopy; fluorescein leakage across the blood-aqueous barrier, as measured by fluorophotometry; and the rating of efficacy by the investigator. No significant differences were seen between ketorolac and either glucocorticoid in cells and flare. No significant differences were found in other signs of inflammation, except conjunctival hyperemia and Descemet's folds at week 2. Ketorolac showed significantly greater efficacy than the glucocorticoids against blood-aqueous barrier breakdown at day 5 and week 2, as demonstrated by the difference in fluorescein concentration between the operated and nonoperated eyes. Investigators did not detect any significant difference in rating for overall effectiveness and acceptability. These findings support the use of ketorolac as an alternative to glucocorticoids for the treatment of postoperative inflammation.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Clinical Therapeutics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Araie M
        • Takase M
        Effects of S-596 and carteolol, new beta-adrenergic blockers, and flurbiprofen on the human eye: A fluorophotometric study.
        Graefe's Arch Clin Exp Ophthalmol. 1985; 222: 259-262
        • Sawa M
        • Araie M
        • Tanishima T
        A fluorophotometric study of the barrier functions in the anterior segment of the eye after intracapsular cataract extraction.
        Jpn J Ophthalmol. 1983; 27: 404-415
        • Sanders DR
        • Kraff M
        Steroidal and non-steroidal anti-inflammatory agents. Effect on postsurgical inflammation and blood-aqueous humor barrier breakdown.
        Arch Ophthalmol. 1984; 102: 1453-1456
        • Flach AJ
        • Graham J
        • Kruger LP
        • et al.
        Quantitative assessment of postsurgical breakdown of the blood-aqueous barrier following administration of 0.5% ketorolac tromethamine solution: A double-masked, paired comparison with vehicle-placebo solution study.
        Arch Ophthalmol. 1988; 106: 344-347
        • Miyake K
        • Asakura M
        • Maekubo K
        Consensual reactions of human blood-aqueous barrier to implant operations.
        Arch Ophthalmol. 1984; 102: 558-561
        • Blaydes JE
        • Kelley EP
        • Walt JG
        • et al.
        Flurbiprofen 0.03% for the control of inflammation following cataract extraction by phacoemulsification.
        J Cataract Refractive Surg. 1993; 19: 481-487
        • Flach AJ
        • Lavelle CJ
        • Olander KW
        • et al.
        The effect of ketorolac tromethamine solution 0.5% in reducing postoperative inflammation after cataract extraction and intraocular lens implantation.
        Ophthalmology. 1988; 95: 1279-1284
        • Araie M
        • Sawa M
        • Takase M
        Topical flurbiprofen and diclofenac suppress blood-aqueous barrier breakdown in cataract surgery: A fluorophotometric study.
        Jpn J Ophthalmol. 1983; 27: 535-542
        • Flach AJ
        • Kraff MC
        • Sanders DR
        • Tanenbaum L
        The quantitative effect of 0.5% ketorolac tromethamine solution and 0.1% dexamethasone sodium phosphate solution on postsurgical blood-aqueous barrier.
        Arch Ophthalmol. 1988; 106: 480-483
        • Drews RC
        Management of postoperative inflammation: Dexamethasone versus flurbiprofen, a quantitative study using the new flare cell meter.
        Ophthalmic Surg. 1990; 21: 560-562
        • Kraff MC
        • Sanders DR
        • McGuigan L
        • Raanan MG
        Inhibition of blood-aqueous humor barrier breakdown with diclofenac: A fluorophotometric study.
        Arch Ophthalmol. 1990; 108: 380-383
        • Buckley MMT
        • Brogden RN
        Ketorolac. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.
        Drugs. 1990; 39: 86-109
        • Flach AJ
        • Jaffe NS
        • Akers WA
        The effect of ketorolac tromethamine in reducing postoperative inflammation: Double-mask parallel comparison with dexamethasone.
        Ann Ophthalmol. 1989; 21: 407-411
        • Flach AJ
        • Dolan BJ
        • Irvine AR
        Effectiveness of ketorolac tromethamine 0.5% ophthalmic solution for chronic aphakic and pseudophakic cystoid macular edema.
        Am J Ophthalmol. 1987; 103: 479-486
        • Tinkelman DG
        • Rupp G
        • Kaufman H
        • et al.
        Double-masked, paired-comparison clinical study of ketorolac tromethamine 0.5% ophthalmic solution compared with placebo eyedrops in the treatment of seasonal allergic conjunctivitis.
        Surv Ophthalmol. 1993; 38 (Suppl): 133-140
        • Ballas Z
        • Blumenthal M
        • Tinkelman DG
        • et al.
        Clinical evaluation of ketorolac tromethamine 0.5% ophthalmic solution for the treatment of seasonal allergic conjunctivitis.
        Surv Ophthalmol. 1993; 38 (Suppl): 141-148
        • Sanders DR
        • Kraff MC
        • Lieberman HL
        • et al.
        Breakdown and reestablishment of blood-aqueous barrier with implant surgery.
        Arch Ophthalmol. 1982; 100: 588-590
        • US Food and Drug Administration
        2nd ed. COSTART: Coding Symbols for Thesaurus of Adverse Reaction Terms. Center for Drugs and Biological Products Experience, Rockville, Md1985 (Publication no. HFN-735)
        • Kuritz SJ
        • Landis RJ
        • Koch GG
        A general overview of Mantel-Haenszel methods: Applications and recent developments.
        Annu Rev Public Health. 1988; 9: 123-160
        • Lehmann EL
        Nonparametrics: Statistical Methods Based on Ranks. Holden-Day, San Francisco1975
        • Kronfeld PC
        • Lin CK
        • Luo TH
        The protein content of re-formed aqueous humor in man.
        Am J Ophthalmol. 1941; 24: 264-276
        • Eakins KE
        Prostaglandin and non-prostaglandin mediated breakdown of the blood-aqueous barrier.
        Exp Eye Res. 1977; (Suppl): 483-498
        • Novack GD
        • Leopold IH
        The blood-aqueous and blood-brain barriers to permeability.
        Am J Ophthalmol. 1988; 105: 412-416
        • Neufeld AH
        • Jampol LM
        • Sears ML
        Aspirin prevents the disruption of the blood-aqueous barrier in the rabbit eye.
        Nature. 1972; 238: 158-159
        • Van Haeringen NJ
        • Glasius E
        • Oosterhuis JA
        • van Delft JL
        Drug prevention of blood-aqueous barrier disruption.
        Ophthalmic Res. 1983; 15: 180-184
        • Mahoney JM
        • Waterbury LD
        Drug effects on the neovascularization response to silver nitrate cauterization of the rat cornea.
        Curr Eye Res. 1985; 4: 531-535